Publication: Evaluation of a single oral dose of diethylcarbamazine 300 mg as provocative test and simultaneous treatment in myanmar migrant workers with Wuchereria bancrofti infection in Thailand
Issued Date
2004-09-01
Resource Type
ISSN
01251562
Other identifier(s)
2-s2.0-8444243386
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Southeast Asian Journal of Tropical Medicine and Public Health. Vol.35, No.3 (2004), 591-598
Suggested Citation
Adisak Bhumiratana, Chumsin Siriaut, Surachart Koyadun, Pratana Satitvipawee Evaluation of a single oral dose of diethylcarbamazine 300 mg as provocative test and simultaneous treatment in myanmar migrant workers with Wuchereria bancrofti infection in Thailand. Southeast Asian Journal of Tropical Medicine and Public Health. Vol.35, No.3 (2004), 591-598. Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/21542
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Evaluation of a single oral dose of diethylcarbamazine 300 mg as provocative test and simultaneous treatment in myanmar migrant workers with Wuchereria bancrofti infection in Thailand
Other Contributor(s)
Abstract
We assessed the efficiency of oral diethylcarbamazine (DEC) 300 mg as a provocative test on blood examination 30 minutes after administration, while gauging the overall infection rate in Myanmar migrant workers with Wuchereria bancrofti infection who enrolled for work permits in Thailand in 2002, using circulating filarial antigens (CFA) assays, the NOW® ICT Filariasis card test and the Og4C3 ELISA as reference. Overall infection rates of 0.3% (95% CI=0-0.7%), 4.2% (95% CI=1.8-6.5%) and 5.9% (95% CI=3.2-8.7%) by three diagnostic tests, respectively, were observed. Among three different location groups of Myanmar population sample tested, there were no statistically significant differences in the overall infection detection rates. When either the ICT card test or the Og4C3 ELISA was used as a reference, the specificity and positive predictive value of the DEC-provocative day test was the same, 100%. The sensitivities were 25.0% (95% CI = 0.5-49.5%) and 17.6% (95% CI = 0-35.8%) on the ICT and ELISA tests, respectively. The negative predictive values were 96.8% (95% CI = 94.8-98.9%) and 95.1% (95% CI = 92.6-97.6%), respectively. In three microfilaremic persons followed-up monitored at 8-weeks DEC post-provocation, there were 6 × 10-1 and 7 × 10 -1 decreases in microfilaremia and antigenemia. These findings suggested that, unlike the CFA assays, the DEC-provocative day test is unsuitable for the diagnosis of active W. bancrofti infection in the population tested, and for gauging current infection prevalence. The treatment would likely be beneficial to reduce microfilaremia and antigenemia.